Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing

Antisense oligonucleotide (ASO)-based therapy is one of the next-generation therapy, especially targeting neurological disorders. Many cases of ASO-dependent gene expression suppression have been reported. Recently, we developed a tocopherol conjugated DNA/RNA heteroduplex oligonucleotide (Toc-HDO)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nucleic Acids Res
Auteurs principaux: Asada, Ken, Sakaue, Fumika, Nagata, Tetsuya, Zhang, Ji-chun, Yoshida-Tanaka, Kie, Abe, Aya, Nawa, Makiko, Nishina, Kazutaka, Yokota, Takanori
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Chemical Biology and Nucleic Acid Chemistry
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8136785/
https://ncbi.nlm.nih.gov/pubmed/33928345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkab258
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires